Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT. J of Skin. 2020;4(6):s85. doi:10.25251/skin.4.supp.85